...
首页> 外文期刊>Journal of health science. >Potent Inhibition of Platelet-Derived Growth Factor-Stimulated Rat Aortic Vascular Smooth Muscle Cell Cycle and Proliferation by (2E)-3-(4-hydroxy-3-methoxy pheny I )pheny I pro-2-en-1 -one, a Newly Synthesized Benzyl ideneacetophenone Derivative
【24h】

Potent Inhibition of Platelet-Derived Growth Factor-Stimulated Rat Aortic Vascular Smooth Muscle Cell Cycle and Proliferation by (2E)-3-(4-hydroxy-3-methoxy pheny I )pheny I pro-2-en-1 -one, a Newly Synthesized Benzyl ideneacetophenone Derivative

机译:血小板衍生生长因子刺激的大鼠主动脉血管平滑肌细胞周期和增殖的强抑制作用由(2E)-3-(4-羟基-3-甲氧基苯基)苯基I pro-2-en-1-one新合成的苄基烯基苯乙酮衍生物

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

One of the principal regulators of mitogene-sis in vascular smooth muscle cells (VSMCs) is platelet-derived growth factor-BB (PDGF-BB). An increase of PDGF-BB expression has been observed in atherosclerotic lesions. The aim of this study was to elucidate the effects and molecular mechanism of (2E)-3-(4-hydroxy-3-methoxyphenyl)phenylpro-2-en-l-one (KTJ2242), a newly synthesized benzylide-neacetophenone derivative, on PDGF-BB-stimulated rat aortic VSMCs. KTJ2242 induced accumulation of cells in the Gl phase of the cell cycle of VSMCs. We observed that KTJ2242 inhibited PDGF-BB-stimulated [~3H]-thymidine incorporation into the DNA of VSMCs, and the cell number was significantly reduced in a concentration-dependent manner.Also, we observed that KTJ2242 decreased PDGF-BB-stimulated extracellular-regulated kinase 1 and 2 (ERK1/2) and Akt phosphorylation. These results suggest the possibility that KTJ2242 may be a potential agent with which to control vascular disorders and its antiproliferative mechanism may be mediated through partial Akt and ERKl/2-dependent signaling pathways.
机译:血管平滑肌细胞(VSMC)中有丝分裂发生的主要调节剂之一是血小板衍生的生长因子-BB(PDGF-BB)。在动脉粥样硬化病变中已经观察到PDGF-BB表达的增加。这项研究的目的是阐明新合成的亚苄基-苯乙酮衍生物(2E)-3-(4-羟基-3-甲氧基苯基)苯基原-2-烯-1-酮(KTJ2242)的作用和分子机理, PDGF-BB刺激的大鼠主动脉VSMC的作用。 KTJ2242在VSMC的细胞周期的G1期诱导细胞蓄积。我们观察到KTJ2242抑制了PDGF-BB刺激的[〜3H]-胸腺嘧啶核苷掺入VSMC的DNA中,并且细胞数量以浓度依赖的方式显着减少。此外,我们观察到KTJ2242减少了PDGF-BB刺激的细胞外增殖。调节的激酶1和2(ERK1 / 2)和Akt磷酸化。这些结果表明,KTJ2242可能是控制血管疾病的潜在药物,其抗增殖机制可能通过部分Akt和ERK1 / 2依赖性信号通路介导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号